FindTrial
Sign In

Prevalence of non-standard dose of new oral anticoagulants in Thai patients.

Prevalence of non-standard dose of new oral anticoagulants in Thai patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190503004
Enrollment
Unknown
Registered
2019-05-03
Start date
2017-08-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical error

Interventions

the dosage that following ACCP 2012 guideline&#44
EHRA guideline,over the standard dose that following ACCP 2012 guideline&#44
EHRA guideline,below the standard dose that following ACCP 2012 guideline&#44
EHRA guideline
Treatment,Treatment,Treatment
proper dose,over dose,under dose

Sponsors

Ratchadaphiseksomphot Endowment Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who received any new oral anticoagulant in all indication

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
non-standard dose 12 months The dose is different from the standard dose referenced from ACCP 2012 guideline—

Secondary

MeasureTime frame
the factors affecting the prescription of physician 12 months multiple logistic regression analysis—

Countries

Thailand

Contacts

Public ContactPitchayathinan Jiratchayachote

Unaffiliated

markwish_10@hotmail.com0866691555

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026